Alvarez-Rodriguez B, Velandia-Alvarez S, Toft C, Geller R
PLoS Biol. 2024; 22(7):e3002709.
PMID: 39012844
PMC: 11251597.
DOI: 10.1371/journal.pbio.3002709.
Callon D, Glenet M, Lebreil A, Heng L, Bouland N, Fichel C
PLoS Pathog. 2024; 20(5):e1012125.
PMID: 38696536
PMC: 11093299.
DOI: 10.1371/journal.ppat.1012125.
Xu C, Wang M, Cheng A, Yang Q, Huang J, Ou X
Front Immunol. 2024; 15:1365521.
PMID: 38629064
PMC: 11018997.
DOI: 10.3389/fimmu.2024.1365521.
Koh J, Masomian M, Anasir M, Ong S, Poh C
Vaccines (Basel). 2023; 11(3).
PMID: 36992213
PMC: 10059274.
DOI: 10.3390/vaccines11030629.
Chen S, Wu J, Yang X, Sun Q, Liu S, Rashid F
Microbiol Spectr. 2022; 10(5):e0272922.
PMID: 35980196
PMC: 9603181.
DOI: 10.1128/spectrum.02729-22.
Lethal Mutagenesis of RNA Viruses and Approved Drugs with Antiviral Mutagenic Activity.
Hadj Hassine I, Mhadheb M, Menendez-Arias L
Viruses. 2022; 14(4).
PMID: 35458571
PMC: 9024455.
DOI: 10.3390/v14040841.
A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase.
Shannon A, Fattorini V, Sama B, Selisko B, Feracci M, Falcou C
Nat Commun. 2022; 13(1):621.
PMID: 35110538
PMC: 8810794.
DOI: 10.1038/s41467-022-28113-1.
Within and Beyond the Nucleotide Addition Cycle of Viral RNA-dependent RNA Polymerases.
Gong P
Front Mol Biosci. 2022; 8:822218.
PMID: 35083282
PMC: 8784604.
DOI: 10.3389/fmolb.2021.822218.
Higher-order structures of the foot-and-mouth disease virus RNA-dependent RNA polymerase required for genome replication.
Loundras E, Streetley J, Herod M, Thompson R, Harris M, Bhella D
Commun Biol. 2022; 5(1):61.
PMID: 35039618
PMC: 8764057.
DOI: 10.1038/s42003-021-02989-z.
A defective viral genome strategy elicits broad protective immunity against respiratory viruses.
Xiao Y, Lidsky P, Shirogane Y, Aviner R, Wu C, Li W
Cell. 2021; 184(25):6037-6051.e14.
PMID: 34852237
PMC: 8598942.
DOI: 10.1016/j.cell.2021.11.023.
Structures and functions of coronavirus replication-transcription complexes and their relevance for SARS-CoV-2 drug design.
Malone B, Urakova N, Snijder E, Campbell E
Nat Rev Mol Cell Biol. 2021; 23(1):21-39.
PMID: 34824452
PMC: 8613731.
DOI: 10.1038/s41580-021-00432-z.
CoV-er all the bases: Structural perspectives of SARS-CoV-2 RNA synthesis.
Malone B, Campbell E, Darst S
Enzymes. 2021; 49:1-37.
PMID: 34696829
PMC: 8381194.
DOI: 10.1016/bs.enz.2021.06.004.
RNA-Dependent RNA Polymerase from Heterobasidion RNA Virus 6 Is an Active Replicase In Vitro.
Levanova A, Vainio E, Hantula J, Poranen M
Viruses. 2021; 13(9).
PMID: 34578320
PMC: 8473416.
DOI: 10.3390/v13091738.
A comparative analysis of parechovirus protein structures with other picornaviruses.
Domanska A, Guryanov S, Butcher S
Open Biol. 2021; 11(7):210008.
PMID: 34315275
PMC: 8316810.
DOI: 10.1098/rsob.210008.
From RNA World to SARS-CoV-2: The Edited Story of RNA Viral Evolution.
Kockler Z, Gordenin D
Cells. 2021; 10(6).
PMID: 34202997
PMC: 8234929.
DOI: 10.3390/cells10061557.
The Picornavirus Precursor 3CD Has Different Conformational Dynamics Compared to 3C and 3D in Functionally Relevant Regions.
Winston D, Boehr D
Viruses. 2021; 13(3).
PMID: 33803479
PMC: 8001691.
DOI: 10.3390/v13030442.
Current and Promising Antivirals Against Chikungunya Virus.
Hucke F, Bugert J
Front Public Health. 2021; 8:618624.
PMID: 33384981
PMC: 7769948.
DOI: 10.3389/fpubh.2020.618624.
Molecular targets and system biology approaches for drug repurposing against SARS-CoV-2.
Singh R, Yadav B, Mohapatra T
Bull Natl Res Cent. 2020; 44(1):193.
PMID: 33230386
PMC: 7675379.
DOI: 10.1186/s42269-020-00444-3.
Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An drug repurposing for COVID-19.
Baby K, Maity S, Mehta C, Suresh A, Nayak U, Nayak Y
F1000Res. 2020; 9:1166.
PMID: 33204411
PMC: 7610171.
DOI: 10.12688/f1000research.26359.1.
Enterovirus Replication Organelles and Inhibitors of Their Formation.
Li X, Wang M, Cheng A, Wen X, Ou X, Mao S
Front Microbiol. 2020; 11:1817.
PMID: 32973693
PMC: 7468505.
DOI: 10.3389/fmicb.2020.01817.